SUMMARY A radioactive cDNA probe complementary to chlamydial ribosomal RNA was used to detect C trachomatis in urogenital specimens. Of 37 specimens positive with cell culture 31 were confirmed by the rRNA:cDNA hybridisation test, the sensitivity being 83.8%. The specificity of the hybridisation test was 94.4%, as 186 of 197 specimens that were negative by cell culture were also negative when assessed by the hybridisation method. Given a prevalence of 15.8% the predictive values for positive and negative results were 73.8% and 96.9%, respectively. In additional experiments the possible role of microorganisms added to the specimen collection medium was investigated. However, no indication for crosshybridisation was found; at high concentrations microorganisms interfered with the test procedure.
Chlamydia trachomatis is the most common agent of sexually transmitted diseases in western countries. 2 The mild and often asymptomatic course ofurogenital chlamydia infection requires the microbiological investigation ofpatients and even the screening of risk populations for an effective epidemiological control.
The routine detection of C trachomatis cannot yet be considered adequate. Indeed the isolation in cell culture is the method ofchoice but the performance of cell culture is limited owing to the cost, the requirement of specialised facilities and restricted transportation of specimens because of a low viability of chlamydia.36 An improvement with respect to these limitations was the introduction of antigen detection tests using specific antibody either with immunofluorescence' or in enzyme-immunoassays.7910
However, these tests cannot fully satisfy the requirements either. Especially in populations with low prevalence of chlamydial infections the sensitivity of antigen detection tests turned out to be relatively low.À new approach to this issue is DNA-hybridisation technique'213 which has so far not yet been sufficiently evaluated. In particular the different technical variations of this method regarding the kind of nucleic acid probes used, the mode ofhybridisation and the type of the visualisation system need further investigation before a final estimation of the relevance of hybridisation technology for routine diagnosis of C trachomatis can be given. In this study a hybridisation assay that allows the detection of C trachomatis ribosomal RNA (rRNA) in the soluble phase of the transport medium by a radio-labelled complementary DNA-probe was evaluated. In addition the possible role ofmicroorganisms present in the urogenital tract to interfere with the test procedure has been investigated. The transport medium contains substances to release rRNA from microorganisms. Transport medium (50 pl) was transferred to a tube and 100 p1 '25I-labelled DNA probe (Gen-Probe, Inc., San Diego) complementary to C trachomatis rRNA were added. The tubes were then placed in a waterbath and incubated for 2 hours at 60°C to form stable rRNA:cDNA hybrids. Afterwards 2 ml separation reagent containing buffer and magnetic particles was added to the tubes and incubation continued at 60°C for 5 min to allow magnetic particles to bind double-stranded rRNA:cDNA hybrids. Next, the tubes were placed on a magnetic separation base (Gen-Probe, Inc., San Diego) resulting in separation of magnetic particle bound hybrids from the remaining non-hybridised probes and after 2 min of holding the tubes and the base together tubes were decanted. By this procedure hybrids bound to magnetic particles were retained in Naher, Niebauer, Hartmann, Soltz-Szots, Petzoldt the tubes whereas the remaining unbound cDNAprobe was removed. Afterwards the tubes were washed with 1 In comparison with the results obtained with cell culture the DNA-hybridisation assay in six specimens could not detect C trachomatis. Since the specificity of the cell culture, the golden standard of chlamydia diagnosis, is generally regarded to be near 100%, it has to be assumed that in cases of discrepant results actually the hybridisation assay and not cell culture failed in the diagnosis of C trachomatis infections. The number of inclusions in the cell cultures inoculated with the specimens yielding discrepant negative results in the hybridisation test were less than five. This suggests that at lower copy numbers of chlamydial rRNA the detection level of the hybridisation assay may be reached.
There were 11 discordant positive results obtained with the DNA-hybridisation assay which could not be confirmed by cell culture. In these cases on the one hand cell culture may partially have failed, since cell culture, although it is generally considered the most sensitive method does not reach 100%."'7 Failures of the cell culture were, however, minimised in our study since for the detection of inclusions fluoresceinlabelled antibodies were used and in the cases the DNA-hybridisation assay yielded discordant positive results cell culture was repeated and passage performed once. Thus discordant positive results of the hybridisation assay may on the other hand comprise cases of actual false-positive results partially resulting for instance from the presence of other bacteria which may interfere with the test system.
As demonstrated in additional experiments false positive results can principally occur in the test evaluated owing to the presence of large numbers of other microorganisms in the specimens. Two explanations seem possible: nucleic acid sequences of other microorganisms crosshybridise with the DNA-probe or microorganisms interfere nonspecifically with the test procedure. Since the false positive results obtained in the additional experiments did not occur selectively with only certain genetically related species of microorganisms, crosshybridisation is very unlikely to be the cause of the false positive results. The finding that false positive results were observed with concentrations approximately within the same range, with all species ofmicroorganisms argues rather for the second explanation. As a consequence, contamination of specimens with microorganisms during sampling for instance by touching the vaginal walls with the swab should be avoided.
The feature which makes the available antibodybased direct detection tests not fully satisfactory for the requirements of C trachomatis diagnosis is their lower sensitivity in comparison with cell culture. This problem becomes particularly relevant when populations with a low prevalence of chlamydial infections are investigated. Given the relatively high prevalence of 15.8% in our population the predictive value of positive results was only 73-8% for the DNA hybridisation assay evaluated. This means that in populations with a low prevalence a positive result of the DNA hybridisation test is not more reliable than that of the antigen detection tests. 
